SEARCH

SEARCH BY CITATION

References

  • 1
    Copeland, R. J., Han, G., Hart, G. W., O-GlcNAcomics—Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics. Proteomics Clin. Appl. 2013, 7, 597606.
  • 2
    Ueda, K., Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers. Proteomics Clin. Appl. 2013, 7, 607617.
  • 3
    Ju, T., Wang, Y., Aryal, R. P., Lehoux, S. D. et al., Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers. Proteomics Clin. Appl. 2013, 7, 618631.
  • 4
    Haab, B., McCarter, C., Kletter, D., Tang, H. et al., Prediction of glycan motifs using quantitative analysis of multi-lectin binding: motifs on MUC1 produced by cultured pancreatic cancer cells. Proteomics Clin. Appl. 2013, 7, 632641.
  • 5
    Kuno, A., Sato, T., Shimazaki, H., Unno, S. et al., Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin. Appl. 2013, 7, 642647.
  • 6
    Miyoshi, E., Kamada, Y., Fujii, H., Fujii, H. et al., Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Proteomics Clin. Appl. 2013, 7, 648656.
  • 7
    Kitazume, S., Yoshihisa, A., Yamaki, T., Oikawa, M. et al., Soluble amyloid precursor protein 770 is a novel biomarker candidate for acute coronary syndrome. Proteomics Clin. Appl. 2013, 7, 657663.
  • 8
    Ruhaak, L. R., Nguyen, U. T., Stroble, C., Taylor, S. L. et al., Enrichment strategies in glycomics-based lung cancer biomarker development. Proteomics Clin. Appl. 2013, 7, 664676.
  • 9
    Drake, R., Nyalwidhe, J., Betesh, L., Powers, T. et al., Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin. Appl. 2013, 7, 677689.
  • 10
    Mehta, A., Comunale, M. A., Wang, M., Anbarasan, N. et al., Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma. Proteomics Clin. Appl. 2013, 7, 690700.